Literature DB >> 23251731

Clinical implications of cognitive function in bipolar disorder.

C T Sudhir Kumar1, Sophia Frangou.   

Abstract

In recent years there has been increased interest in cognitive function in bipolar disorder (BD) as a means of understanding and exploring biological mechanisms relating to predisposition, disease expression and outcome. Despite significant methodological differences between studies we can begin to discern meaningful patterns from existing data. The evidence reviewed suggests that: (a) premorbid cognitive dysfunction is not a dominant feature of BD; in contrast to other severe psychiatric conditions, enhanced cognitive function may be a risk marker for BD; (b) in BD patients with established syndromal disease, trait-related cognitive impairment is reliably seen in the speed of information processing, verbal Learning and memory and response inhibition; (c) cognitive function appears to remain stable post-disease onset in the majority of patients although the risk of dementia in old age is increased; (d) cognitive impairment is a key predictor of functional outcome in BD. These findings underscore the importance of cognition in BD as a marker of neural integrity across all phases of the illness and as a therapeutic target in disability reduction.

Entities:  

Keywords:  Longitudinal; bipolar disorder; cognition; disease expression; executive function; general intellectual function; memory; outcome; premorbid

Year:  2010        PMID: 23251731      PMCID: PMC3513860          DOI: 10.1177/2040622310374678

Source DB:  PubMed          Journal:  Ther Adv Chronic Dis        ISSN: 2040-6223            Impact factor:   5.091


  51 in total

1.  Predictors of outcome in a representative population of bipolar disorder.

Authors:  Sophia Frangou
Journal:  Bipolar Disord       Date:  2002       Impact factor: 6.744

2.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort.

Authors:  Mary Cannon; Avshalom Caspi; Terrie E Moffitt; HonaLee Harrington; Alan Taylor; Robin M Murray; Richie Poulton
Journal:  Arch Gen Psychiatry       Date:  2002-05

3.  Cognitive function in euthymic bipolar I disorder.

Authors:  J K Zubieta; P Huguelet; R Lajiness-O'Neill; B J Giordani
Journal:  Psychiatry Res       Date:  2001-05-10       Impact factor: 3.222

4.  A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.

Authors:  Abraham Reichenberg; Mark Weiser; Jonathan Rabinowitz; Asaf Caspi; James Schmeidler; Mordechai Mark; Zeev Kaplan; Michael Davidson
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

Review 5.  Neuropsychology of bipolar disorder: a review.

Authors:  Seema Quraishi; Sophia Frangou
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

6.  The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.

Authors:  T Suppes; G S Leverich; P E Keck; W A Nolen; K D Denicoff; L L Altshuler; S L McElroy; A J Rush; R Kupka; M A Frye; M Bickel; R M Post
Journal:  J Affect Disord       Date:  2001-12       Impact factor: 4.839

7.  The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder.

Authors:  Stuart Donaldson; Laura H Goldstein; Sabine Landau; Vanessa Raymont; Sophia Frangou
Journal:  J Clin Psychiatry       Date:  2003-01       Impact factor: 4.384

8.  Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses.

Authors:  Lars Vedel Kessing; Flemming Mørkeberg Nilsson
Journal:  J Affect Disord       Date:  2003-02       Impact factor: 4.839

9.  Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.

Authors:  Anabel Martínez-Arán; Eduard Vieta; María Reinares; Francesc Colom; Carla Torrent; Jose Sánchez-Moreno; Antonio Benabarre; José Manuel Goikolea; Mercè Comes; Manel Salamero
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

Review 10.  Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders.

Authors:  Glenda Macqueen; Trevor Young
Journal:  Bipolar Disord       Date:  2003       Impact factor: 6.744

View more
  4 in total

Review 1.  A systems neuroscience perspective of schizophrenia and bipolar disorder.

Authors:  Sophia Frangou
Journal:  Schizophr Bull       Date:  2014-03-08       Impact factor: 9.306

Review 2.  Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls.

Authors:  Emre Bora; Christos Pantelis
Journal:  Schizophr Bull       Date:  2015-01-23       Impact factor: 9.306

3.  Brain network analysis reveals affected connectome structure in bipolar I disorder.

Authors:  Guusje Collin; Martijn P van den Heuvel; Lucija Abramovic; Annabel Vreeker; Marcel A de Reus; Neeltje E M van Haren; Marco P M Boks; Roel A Ophoff; René S Kahn
Journal:  Hum Brain Mapp       Date:  2015-10-10       Impact factor: 5.038

Review 4.  Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews.

Authors:  Michele Fornaro; Domenico De Berardis; Giampaolo Perna; Marco Solmi; Nicola Veronese; Laura Orsolini; Elisabetta Filomena Buonaguro; Felice Iasevoli; Cristiano André Köhler; André Ferrer Carvalho; Andrea de Bartolomeis
Journal:  Biomed Res Int       Date:  2017-05-09       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.